Secondary Myelofibrosis Recruiting Phase 2 Trials for Proline (DB00172)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02370329P1101 in Treating Patients With MyelofibrosisTreatment